COMMUNIQUÉS West-GlobeNewswire

TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada

28/06/2018 - 22:05

TESARO to Receive $40 Million, plus Potential for Additional Milestone Payments and Royalties TESARO Retains ex-North America Rights and Continues to Market VARUBY ® in Europe WALTHAM, Mass., June 28, 2018 (GLOBE [...]

electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation (nVNS) in Headache Disorders at the 60th Annual Meeting of the American Headache Society

28/06/2018 - 22:01

BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, announced today it will present six abstracts across three primary headache [...]

Ziopharm Oncology Enrolls First Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO®

28/06/2018 - 22:01

Phase 1 trial to evaluate Ad-RTS-hIL-12 plus veledimex in combination with nivolumab for treatment of recurrent glioblastoma BOSTON, June 28, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a [...]

MAC Clinical Research Announces Presentation at the 60th Annual Scientific Meeting of the American Headache Society

28/06/2018 - 22:01

– New clinical trial data highlight potential of an evoked migraine model to test potential efficacy for investigational products intended to treat acute migraine – – Collaboration between MAC Clinical Research and [...]

Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients

28/06/2018 - 22:01

Gemcabene demonstrated statistically significant lowering of triglycerides (TGs) in SHTG Secondary endpoints achieved included statistically significant reductions in serum LDL-C, non-HDL-C, VLDL-C, apoB, apoE, apoCIII [...]

Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine

28/06/2018 - 22:01

– Pharmacokinetics, safety, and tolerability support advancement of TRV250 to Phase 2 – – Data suggest potential for TRV250 to be the first selective delta receptor modulator – CHESTERBROOK, Pa., June 28, 2018 (GLOBE [...]

ALRT announces launch of the Integrated ALRT Diabetes Solution (“Integrated Solution”)

28/06/2018 - 21:58

The Integrated Solution will include ALRT Diabetes Solution software, blood glucose test supplies and diabetes management administered by Centers of Excellence for Diabetes Care RICHMOND, Va., June 28, 2018 (GLOBE [...]

CAPS® Expert Appointed to the Board of Pharmacy Specialties’ Council

28/06/2018 - 20:50

IRVINE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS ® ) is proud to announce that Sharon Durfee, RPh, BCNSP, has been selected as a member of the Board of Pharmacy [...]

League and Molecular You Partner to Provide Employees with Personalized Health Assessments for Early Detection and Preventive Healthcare

28/06/2018 - 18:30

Opens up personal health assessments to the whole workforce VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- League Inc., the disruptive health benefits platform, and Molecular You, the personalized health [...]

NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards

28/06/2018 - 18:27

“Moving Beyond Opioids: How Technological Innovations Can Impact Chronic Pain” earns top award in healthcare publicity campaign category WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) [...]

NEOVACS : SUSPENSION DE COURS

28/06/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE SUSPENSION DE COURS Paris et Boston, le 28 juin 2018 - 18 : 00 pm CEST - Néovacs (Euronext Growth Paris : ALNEV), a demandé à Euronext Paris la [...]

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

28/06/2018 - 18:01

LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the acquisition of PCI [...]

electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

28/06/2018 - 17:45

BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today announced that the underwriters of its previously announced initial public offering of common stock have [...]

Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers

28/06/2018 - 17:37

DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based offering for payers and [...]

Tivity Health to Issue Second Quarter 2018 Financial Results After Market Close on August 2

28/06/2018 - 17:00

Company to Host Conference Call and Live Webcast Nashville, Tenn., June 28, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY) today announced that its financial results for the second quarter ending June 30, [...]

Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018

28/06/2018 - 17:00

CINCINNATI, June 28, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading life science company, expects to release its third quarter fiscal 2018 operating results before the NASDAQ market opens on [...]

MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens

28/06/2018 - 16:34

The collaboration with AbCheck will allow MolMed to enlarge its proprietary CAR pipeline for both liquid and solid malignancies Milan (Italy) and Plzen (Czech Republic), June 28 th 2018 - MolMed S.p.A. (MLMD.MI), a [...]

Abattis Enters Into Definitive Agreement to Launch New Cannabis Lab in Ontario

28/06/2018 - 16:29

VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive investment [...]

CORRECTION - Hydropothecary déclare les résultats du troisième trimestre de l’exercice 2018

28/06/2018 - 16:20

GATINEAU, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Veuillez noter qu'une correction a été apportée au communiqué de presse diffusé ce 28 juin 2018, à 6 h 30 HAE. Dans le paragraphe sous " À propos de Hexo ", il aurait [...]